Reevaluating the imaging definition of tumor progression: perfusion MRI quantifies recurrent glioblastoma tumor fraction, pseudoprogression, and radiation necrosis to predict survival
about
Quantitative Perfusion and Permeability Biomarkers in Brain Cancer from Tomographic CT and MR ImagesAdvanced magnetic resonance imaging methods for planning and monitoring radiation therapy in patients with high-grade gliomaBiomarker-based adaptive trials for patients with glioblastoma--lessons from I-SPY 2A Gamma-Knife-Enabled Mouse Model of Cerebral Single-Hemisphere Delayed Radiation NecrosisRecent Application of Advanced MR Imaging to Predict Pseudoprogression in High-grade Glioma PatientsDiffusion and perfusion weighted magnetic resonance imaging for tumor volume definition in radiotherapy of brain tumorsThe basics of diffusion and perfusion imaging in brain tumorsTreatment-related brain tumor imaging changes: So-called "pseudoprogression" vs. tumor progression: Review and future research opportunitiesPotential role of preoperative conventional MRI including diffusion measurements in assessing epidermal growth factor receptor gene amplification status in patients with glioblastomaRadiotherapy of high-grade gliomas: current standards and new concepts, innovations in imaging and radiotherapy, and new therapeutic approachesThe role of imaging in the management of progressive glioblastoma : a systematic review and evidence-based clinical practice guideline.Advanced magnetic resonance imaging of the physical processes in human glioblastoma.Pitfalls in the neuroimaging of glioblastoma in the era of antiangiogenic and immuno/targeted therapy - detecting illusive disease, defining response.Characterization of pseudoprogression in patients with glioblastoma: is histology the gold standard?ASFNR recommendations for clinical performance of MR dynamic susceptibility contrast perfusion imaging of the brain.Tumour Relapse Prediction Using Multiparametric MR Data Recorded during Follow-Up of GBM Patients.Applying amide proton transfer-weighted MRI to distinguish pseudoprogression from true progression in malignant gliomasQuantitative multiparametric MRI assessment of glioma response to radiotherapy in a rat modelAnalysis of heterogeneity in T2-weighted MR images can differentiate pseudoprogression from progression in glioblastoma.Evaluation of pseudoprogression in patients with glioblastoma multiforme using dynamic magnetic resonance imaging with ferumoxytol calls RANO criteria into question.Survival analysis in patients with newly diagnosed primary glioblastoma multiforme using pre- and post-treatment peritumoral perfusion imaging parameters.Delayed contrast extravasation MRI for depicting tumor and non-tumoral tissues in primary and metastatic brain tumors.Physiologic MRI for assessment of response to therapy and prognosis in glioblastoma.Delayed contrast extravasation MRI: a new paradigm in neuro-oncologyMulti-Parametric MRI and Texture Analysis to Visualize Spatial Histologic Heterogeneity and Tumor Extent in Glioblastoma.Differentiating Radiation-Induced Necrosis from Recurrent Brain Tumor Using MR Perfusion and Spectroscopy: A Meta-AnalysisRepeatability of Standardized and Normalized Relative CBV in Patients with Newly Diagnosed Glioblastoma.MR perfusion-weighted imaging in the evaluation of high-grade gliomas after treatment: a systematic review and meta-analysis.Comparison of perfusion- and diffusion-weighted imaging parameters in brain tumor studies processed using different software platformsLong-Term Follow-up of 25 Cases of Biopsy-Proven Radiation Necrosis or Post-Radiation Treatment Effect Treated With Magnetic Resonance-Guided Laser Interstitial Thermal Therapy.Molecular MRI differentiation between primary central nervous system lymphomas and high-grade gliomas using endogenous protein-based amide proton transfer MR imaging at 3 Tesla.MR-guided radiation therapy: transformative technology and its role in the central nervous system.Semi-automated brain tumor segmentation on multi-parametric MRI using regularized non-negative matrix factorizationDifferentiation of high-grade and low-grade diffuse gliomas by intravoxel incoherent motion MR imagingAn Update on the Approach to the Imaging of Brain Tumors.Impact of Software Modeling on the Accuracy of Perfusion MRI in Glioma.Early Cerebral Blood Volume Changes Predict Progression After Convection-Enhanced Delivery of Topotecan for Recurrent Malignant Glioma.Classifying Glioblastoma Multiforme Follow-Up Progressive vs. Responsive Forms Using Multi-Parametric MRI Features.Application of PET-MRI in pseudo progression versus true progression in High Grade Gliomas: A new avenue!Diagnostic and therapeutic avenues for glioblastoma: no longer a dead end?
P2860
Q26743358-9E091F35-D8E8-490D-BBEA-11473E95C8C8Q26826862-A404E038-0AF2-486E-9A4E-D3514FBE7141Q27010096-6004DEA6-9CF1-445F-9614-B01BC4774967Q27315120-464B0D42-97EC-4152-B4BA-C46C27F4378FQ28066044-5DD583C7-C97F-487C-BC08-BAAB8B5848D6Q28067114-57221075-2555-48F0-9833-439969DCD648Q28606582-4CBB41AB-2964-4BA7-90F5-139E258CA698Q30627773-62BC6C6E-9E1F-4AFD-A720-DDFC99A6B297Q30652283-DEC12042-A2ED-436D-A401-1B7E1AAE63E1Q30725125-B03972DB-5EDD-4BA4-9DC1-6DC14CF06F55Q30797166-3F285D04-C577-4E5B-875C-6782ECFBE3AEQ30847284-DD366C60-D6AD-4ADC-B00B-BE6F86D47821Q30907831-82157476-D9BE-4AE4-9C3B-48A41AB45329Q30937034-C43EC10E-4558-42C3-9023-AD3D4FDA6E90Q30938805-2316A24E-6559-43DF-9919-DB8B75CC0397Q30998509-0E5B2B9E-327C-46D1-98DB-E6CC7FD990F8Q31038332-229FA339-106F-48A5-A954-6AEED1DC16C0Q33616603-A77B7DC0-FE73-4A6C-94F6-61EBD202CE0DQ33698886-357B5B3C-9797-4F85-9B34-D52FFB4A0A51Q33894461-5804B30E-1C4B-498D-826F-4FF642871609Q34389144-647D05A9-1676-44AC-8F8B-BE45E922793CQ34517492-49B0071A-E717-4E12-8BB6-DC7426587DF4Q35771783-1FC3FF0C-383C-4074-B5E5-012C29724D74Q35788925-EEDE9672-ADE9-4030-96FC-E2AFD56490BCQ35849699-1E60E141-5F7B-4AB3-ABA1-26A26F8C5065Q35888150-6934D0A2-7765-4A63-8DA7-34E29BDCE7BAQ36054267-A2EC9C34-9941-4EC5-B127-84BE8C51E701Q36097886-F49EDB74-1D2A-4DD7-AF47-EE09305A9633Q36165361-6C3FA2EC-29A2-455A-97D5-DEE7DD0623E8Q36196965-D3F389FF-C375-46CF-8AD4-E9FE2C9A5451Q36233629-4BA48E1A-7C02-43C9-9384-6CD139E7A277Q36336361-A92C1C2B-6BEA-42F6-9521-56A8F3335046Q36363620-EC709FFE-E19A-4085-88D0-E5841C487014Q36367421-E4E1CC67-1DF2-4603-A54E-F371E760F725Q36374577-571FEFB4-DC55-41E0-9F46-1836BA7E6EC4Q36378153-E7D4D05A-AD3C-449D-AC6B-7C8727A4EA10Q37042108-8E695B2C-69F5-4B88-93CD-D35F8D2053F4Q37578230-779AC3F8-A047-4BF0-84BA-A39FBCC5B016Q37700853-9E447F88-50A0-42A4-828B-F5BF0169ACACQ38062793-FE04AEB5-20B5-4DC3-8F9D-F6A6C7372A2C
P2860
Reevaluating the imaging definition of tumor progression: perfusion MRI quantifies recurrent glioblastoma tumor fraction, pseudoprogression, and radiation necrosis to predict survival
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Reevaluating the imaging defin ...... n necrosis to predict survival
@ast
Reevaluating the imaging defin ...... n necrosis to predict survival
@en
type
label
Reevaluating the imaging defin ...... n necrosis to predict survival
@ast
Reevaluating the imaging defin ...... n necrosis to predict survival
@en
prefLabel
Reevaluating the imaging defin ...... n necrosis to predict survival
@ast
Reevaluating the imaging defin ...... n necrosis to predict survival
@en
P2093
P2860
P356
P1433
P1476
Reevaluating the imaging defin ...... n necrosis to predict survival
@en
P2093
Amylou C Dueck
Burt G Feuerstein
Jennifer M Eschbacher
John P Karis
Josef Debbins
Joseph E Heiserman
Kris A Smith
Leland S Hu
Leslie C Baxter
P2860
P304
P356
10.1093/NEUONC/NOS112
P577
2012-05-03T00:00:00Z